ADVERTISEMENT
Posted: Apr 7, 2020

Reevaluating chlorthalidone as thiazide ‘diuretic of choice’

Hypertension

The 2017 American College of Cardiology/American Heart Association guidelines on management of hypertension currently recommend use of thiazide diuretics as first-line agents.

Maria G. Tanzi, PharmD

Read more
Posted: Apr 7, 2020

As one drug leaves the weight-loss market, many options remain

Obesity

In February, Eisai removed the weight-loss drug lorcaserin (Belviq, BelviqXR) from the market at FDA’s request.

Sonya Collins

Read more
Posted: Apr 7, 2020

First oral nonstatin drugs approved for high cholesterol in nearly 20 years

New Drug

FDA recently approved bempedoic acid (Nexletol), the first once-daily, oral nonstatin drug to lower LDL-C in nearly 20 years, as well as bempedoic acid and ezetimibe (Nexlizet), the first nonstatin combination drug ever approved.

Cara Aldridge Young

Read more
Posted: Apr 7, 2020

NSAIDs for COVID-19

On The Shelf

After a research article published in Lancet on March 11 indicated that use of ibuprofen may worsen COVID-19 symptoms, and the subsequent media attention, patients are wary of taking NSAIDs in case they may be infected with coronavirus.

Mary Warner

Read more
Posted: Apr 7, 2020

Self-care and COVID-19

OTCs Today

The COVID-19 crisis is affecting our lives in more ways than we could possibly imagine.

Daniel L. Krinsky, RPh, MS

Read more
First4243444547495051
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT